Key facts
- It has raised $630K; the latest was Angel (individual) ($630K) in Dec 2024.
- Notable investors include Jacques-Antoine Granjon, Letartre Bertrand, Reza Malekzadeh.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Mabel (Consumer Non-Durables)
- ·The full record, as it builds
Funding rounds
No funding rounds for Mabel (Consumer Non-Durables) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mabel (Consumer Non-Durables)
Operator of a wellness and mental health firm intended to address women's mental health. The company specializes in psychedelics, personal self-development, and functional mushrooms, enabling customers to help rewire the brain for calm, clarity, and joy.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Paris, France
- Founded
- 2023
- Employees
- 2
- Website
- mabel.life/
- Ownership
- Privately Held (backing)
Mabel (Consumer Non-Durables) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mabel (Consumer Non-Durables) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mabel (Consumer Non-Durables) in its N-PORT filings yet. We sweep new filings monthly.